Piper Jaffray Companies initiated coverage on shares of Health Catalyst (NASDAQ:HCAT) in a research note published on Monday morning, BenzingaRatingsTable reports. The firm issued an overweight rating and a $47.00 target price on the stock. Piper Jaffray Companies also issued estimates for Health Catalyst’s Q2 2019 earnings at ($0.40) EPS, Q3 2019 earnings at ($0.40) EPS, Q4 2019 earnings at ($0.24) EPS, FY2019 earnings at ($1.43) EPS, Q1 2020 earnings at ($0.30) EPS, Q2 2020 earnings at ($0.24) EPS, Q3 2020 earnings at ($0.32) EPS, Q4 2020 earnings at ($0.16) EPS, FY2020 earnings at ($1.03) EPS and FY2021 earnings at ($0.76) EPS.

Several other brokerages have also commented on HCAT. Evercore ISI began coverage on shares of Health Catalyst in a research note on Monday. They set an outperform rating and a $50.00 price target on the stock. Leerink Swann began coverage on shares of Health Catalyst in a research note on Monday. They set an outperform rating and a $55.00 price target on the stock. SunTrust Banks began coverage on shares of Health Catalyst in a research note on Monday. They set a buy rating and a $53.00 price target on the stock. Finally, William Blair began coverage on shares of Health Catalyst in a research note on Monday. They set an outperform rating on the stock. Eight investment analysts have rated the stock with a buy rating, The company currently has a consensus rating of Buy and an average target price of $51.29.

Shares of HCAT opened at $42.94 on Monday. Health Catalyst has a 12 month low of $36.29 and a 12 month high of $49.85.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Featured Article: Why is the price target of stocks important?

Analyst Recommendations for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.